Pharmaceutical company in
Geneva
97 companies in Pharmaceutical company based in Geneva — name and year of registration from the commercial register.
50 of 97 companies
Union for International Cancer Control (UICC)
Since 2006 · 51–100 empl.4.5(6)
Union for International Cancer Control (UICC) is an international organisation that supports efforts to reduce the global burden of cancer. It connects and supports the cancer community through learning and knowledge exchange, advocacy, international events, and work to advance evidence-based cancer prevention and care.
Laboratoires Bailleul International SA
Since 2012 · 11–20 empl.3.7(6)
Laboratoires Bailleul International SA is a pharmaceutical company that develops and markets pharmaceutical products, food supplements and dermocosmetic products. It specialises in dermatology and offers products including hair and skin care ranges.
Servier (Suisse) SA
Since 1978 · 21–50 empl.
Servier (Suisse) SA is the Swiss subsidiary of the Servier Group and promotes and distributes medicines in Switzerland. Its therapeutic areas include oncology, cardiometabolic diseases, depression and venous diseases.
Skinpulse SARL
Since 1994 · 11–20 empl.
Skinpulse SARL is a centre for medical dermatology and aesthetic skin treatments. Its services include diagnosing and treating skin conditions, as well as cosmetic procedures such as laser treatments, microneedling and peels.
Botavie SA
Since 2000 · 1–10 empl.
Botavie SA offers plant-based dietary supplements and health products formulated according to the Unani tradition and markets them online under the BOTAVIE and IRELIA brands.
SOLID Drug Development SA
Since 2010 · 1–10 empl.
The core activity of Solid Drug Development is strategic and operational consulting for the development of biotech and pharmaceutical products. Specifically, the company supports the development of medicines from the laboratory phase to clinical testing and helps reduce costs and operational problems for pharmaceutical companies.
EHC (EUROPEAN HEALTH CORPORATION) SA
Since 2010 · 1–10 empl.
EHC (EUROPEAN HEALTH CORPORATION) SA operates in consumer healthcare and develops products and solutions for health and self-care. Its activities include acquiring, licensing, distributing and promoting brands, with products such as over-the-counter medicines, medical devices and food supplements.
VASPERIS SA
Since 2010 · 11–20 empl.
O'TENTIKA is a cosmetics company specializing in the manufacture and distribution of skin and facial care products. The company's core activity encompasses the development, production, and sale of premium skin care products, particularly in the field of skin refinement and care.
CROSS PHARM SA
Since 2013 · 1–10 empl.
The core activity of Cross Pharm S.A. is the development, manufacture and marketing of high-quality medicines, including antibiotics, antiemetics, muscle relaxants, orexigenics and vitamins as well as minerals.
ReMedys Foundation
Since 2013 · 11–20 empl.
ReMedys Foundation is a not-for-profit foundation that supports translational research and the development of new therapies for patients with severe diseases lacking effective treatments. It brings together academic researchers and industry experts and runs programs focused on healthspan and ALS.
Bailleul (Suisse) SA
Since 2014 · 11–20 empl.
Bailleul (Suisse) SA is a pharmaceutical company specializing in the development and commercialization of medicinal products, dietary supplements and dermo‑cosmetic products.
ADVANCED ACCELERATOR APPLICATIONS INTERNATIONAL SA
Since 2014 · 11–20 empl.
The core activity of Advanced Accelerator Applications (AAA) is the development and delivery of products and services in the field of nuclear medicine, particularly in the areas of radioligand therapy (RLT) and molecular imaging with positron emission tomography (PET).
Santen SA
Since 2014 · 101–500 empl.
Santen SA is a pharmaceutical company focused on ophthalmology. It develops and markets medicines and medical devices, including products for glaucoma and dry eye disease, and also operates in the fields of eye surgery and vision correction.
DermAbiotech Sàrl
Since 2014 · 1–10 empl.
DermAbiotech Sàrl develops targeted therapies for acute T cell–mediated inflammatory diseases. The company focuses on therapeutic candidates designed to modulate T‑cell driven inflammation.
CELL RECEPTOR SA
Since 2015 · 1–10 empl.
CELL RECEPTOR SA develops a novel cell-biology-based therapy for cancer and autoimmune diseases. It researches an extracellular signalling mechanism and develops compounds that block interactions between tumour cells and platelets to reduce tumour growth, metastasis and chemoresistance.
Kyowa Kirin Sàrl
Since 2016 · 21–50 empl.
The core activity of Krystal Biotech, Inc. is the development and manufacture of pharmaceuticals, particularly biopharmaceuticals. The company focuses on the research and development of new therapeutics based on genetic and biotechnological methods. The company's products aim to treat various diseases and conditions, including rare genetic disorders.
Atopia Therapeutics SA
Since 2016 · 1–10 empl.
Atopia Therapeutics SA develops drug candidates for asthma and other allergic diseases. Its candidate ATP-R13 is a recombinant immunomodulatory protein being developed as an oral therapy.
STALICLA SA
Since 2017 · 11–20 empl.
STALICLA SA develops personalized treatment approaches for neurological and neuropsychiatric disorders, particularly autism spectrum disorders. Its DEPI platform uses multiomics, patient data and artificial intelligence to match patient groups with suitable drug treatments.
iOnctura SA
Since 2017 · 21–50 empl.
The core activity of iOnctura is the development of cancer drugs, particularly in oncology immunotherapy, with a focus on solid tumors, uveal melanoma and other types of cancer.
Gliapharm SA
Since 2017 · 11–20 empl.
Gliapharm SA researches and develops drug candidates for neurological disorders by targeting metabolic pathways in astrocytes, a type of glial cell. Its drug discovery platform identifies and characterizes molecular targets and potential medicines, and is also used in research with academic and industry partners.
MPC Therapeutics SA
Since 2018 · 11–20 empl.
MPC Therapeutics SA develops small molecules and reagents for metabolic modulation of cell therapies. Its products support the manufacture and function of CAR-T cells, including by promoting their expansion, metabolic fitness and persistence.
Relief Therapeutics International SA
Since 2018 · 21–50 empl.
Relief Therapeutics International SA develops therapeutic solutions in neurotherapy and digital rehabilitation. The company offers combined approaches that use software, devices, data, and behavior-based applications for therapy and monitoring.
Release Therapeutics SA
Since 2005 · 1–10 empl.
The core activity of Relief Therapeutics is the development and marketing of new, patented therapeutics for rare and ultra-rare diseases, particularly for patients with severe illnesses for which there are currently no or only limited treatment options. The company focuses on developing medications for specific diseases such as Epidermolysis Bullosa, Phenylketonuria and other rare conditions.
Advanced Biotech Laboratories Switzerland SA
Since 2010 · 21–50 empl.
The core activity of Advanced Biotech Laboratories Switzerland SA is the selection and promotion of high-quality anti-aging products and luxury health services, particularly in the field of cell therapy and stem cell research. The company collaborates with various clinics and laboratories to offer innovative products and services in the field of health and beauty.
AMAL THERAPEUTICS SA
Since 2012 · 21–50 empl.5.0(2)
The core activity of AMAL Therapeutics is the development of therapeutic cancer vaccines, particularly using its proprietary KISIMA immunization technology, which aims to stimulate the patient's immune response against cancer cells.
Geneva Biotech Center (GBC) SA
Since 2013 · 11–20 empl.
The core activity of Atopia Tx is the development of innovative therapies for asthma and allergic diseases, in particular the development of a first disease-modifying therapeutic for asthma and allergies based on a molecule from Helicobacter pylori.
Life Episteme Group Sàrl
Since 2013 · 1–10 empl.
PhytoCloud SA
Since 2017 · 1–10 empl.
PhytoCloud SA sells cannabis-derived THC and CBD products such as vape pods, e-liquids, cartridges and olfactory inhalers. The company also offers wholesale and white-label services and personal product formulation, working with Swiss laboratories.
Pharmacros SA
Since 2019 · 1–10 empl.
Pharmacros SA develops and distributes nutritional supplements for daily nutrition and wellness. Its activities include product formulation and supplying products through distribution partnerships.
RegulaNova Sàrl
Since 2020 · 1–10 empl.
Synnergan Sàrl
Since 2021 · 1–10 empl.
The core activity of Synnergan is the development and manufacture of patented dietary supplements, particularly in the areas of fat loss and muscle building. These products are manufactured in Switzerland and are based on scientific findings and research results.
FRILAB SA
Since 2002 · 21–50 empl.4.0(1)
FRILAB SA markets medicines and health products for family health, gynaecology, nutrition and hospitals. It works with manufacturers and healthcare experts and handles activities including product registration, marketing and distribution.
ARmox Pharma Sàrl
Since 2015 · 11–20 empl.5.0(1)
ARmox Pharma Sàrl offers pharmaceutical products, including generic and over-the-counter medicines, as well as vitamins and cosmetics.
Rebio Pharma Sàrl
Since 2025 · 1–10 empl.
Rebio Pharma Sàrl develops targeted, locally delivered therapies for ocular cancer. Its pipeline includes RBP-01 for uveal melanoma and preclinical programmes for retinoblastoma and other eye conditions.
AZURECELL SA
Since 2025 · 1–10 empl.
AZURECELL SA is a biotechnology research company. The website indicates work related to restoring neural function and points to an upcoming focus in neuroscience.
Velden Botanicals S.A.
Since 2025 · 1–10 empl.
Velden Botanicals S.A. supplies botanical ingredients for beauty, flavour, and fragrance manufacturers. The company develops traceable, standardised botanical extracts and fractions and also provides samples and technical documentation for formulation work.
Swiss Armonia Sàrl
Since 2025 · 1–10 empl.
Swiss Armonia Sàrl operates the SwissWay brand for dietary supplements. The company develops and quality-controls its formulas in Switzerland and offers products such as Swiss Vue, along with partner and business solutions.
Columed SA
Since 2010 · 1–10 empl.
Columed SA provides commercial and legal services in the pharmaceutical sector and is also active in pharmaceutical retail. It offers services to both manufacturers and retailers of pharmaceutical products.
Medicoop SA
Since 2019 · 11–20 empl.
Medicoop SA sources and distributes medical products under the MediSphere name for healthcare businesses and organisations. Its portfolio focuses on essential medical devices for professional use, including products for anaesthesia, diagnostics, wound care and surgery.
ApoTalic Sàrl
Since 2025 · 1–10 empl.
ApoTalic Sàrl provides pharmacy cover through an independent pharmacist. Its services include reviewing prescriptions, dispensing medicines and medical devices, and offering pharmaceutical advice; its activities also include coordinating vaccination and testing centres.
Hypericum Suisse Sàrl
Since 2025 · 1–10 empl.
Hypericum Suisse Sàrl offers liposomal food supplements. Its products are presented as having pure formulations and being intended for everyday use.
Nirkana Sàrl
Since 2025 · 1–10 empl.
Nirkana Sàrl cultivates and sells CBD hemp flowers. Its varieties are grown indoors in Switzerland; the products contain less than 1% THC and are sold as plant-based smoking products for adults.
Xelios Pharmaresearch, A. Hügin
Since 2003 · 1–10 empl.
The core activity of Xelios PharmaResearch is the development of new drugs for the treatment of specific skin diseases, in particular the discovery and development of treatments for Molluscum contagiosum, a viral skin infection. The activities include the identification of active ingredients, the acquisition of intellectual property rights and the conduct of clinical trials up to Phase II.
Beijing Tong Ren Tang Swiss SA
Since 2017 · 1–10 empl.
Aleos Bio SA
Since 2025 · 1–10 empl.
Inter Promotion et Publicité SA
Since 1948 · 1–10 empl.
Laboratoire Acbel SA
Since 1958 · 1–10 empl.
Labiol SA
Since 1962 · 1–10 empl.
PROPHARMED INTERNATIONAL SA
Since 1983 · 1–10 empl.
Swiss Medical International SA
Since 2002 · 1–10 empl.
Pharmaceutical company in Geneva
Pharmaceutical company in the region
Point size by number of companies per place.
Source: commercial register (Zefix) · as of November 6, 2026
Pharmaceutical company in other places
By canton